Skip to main content

ADVERTISEMENT

Leslie Citrome, MD

Abstract: Background: HP-3070, a once-daily asenapine transdermal system, is FDA-approved for adults with schizophrenia. The Positive and Negative Syndrome Scale (PANSS) score’s five-fact...
01/19/2023
Introduction: Esketamine nasal spray for management of treatment-resistant depression (TRD) was assessed using the metrics of number needed to treat (NNT), number needed to harm (NNH), an...
11/22/2019
Abstract: Background: Lumateperone is an FDA-approved antipsychotic to treat schizophrenia and depressive episodes associated with bipolar I or bipolar II disorder as monotherapy and as a...
01/19/2023
Background: In a previous study, dasotraline, a long-acting dopamine/norepinephrine reuptake inhibitor, demonstrated efficacy in the treatment of binge-eating disorder (BED). We now repor...
11/22/2019
Headshot of Dr Leslie Citrome on a blue background underneath the PopHealth Perspectives logo.
Podcasts
06/20/2023
Leslie Citrome, MD, clinical professor of psychiatry & behavioral sciences, New York Medical College, Valhalla, and founding director, Clinical Research and Evaluation Facility, Nathan S Kline Institute for Psychiatric Research, discusses why...
Leslie Citrome, MD, clinical professor of psychiatry & behavioral sciences, New York Medical College, Valhalla, and founding director, Clinical Research and Evaluation Facility, Nathan S Kline Institute for Psychiatric Research, discusses why...
Leslie Citrome, MD, clinical...
06/20/2023
Veterans Health Today